Company

Academic Technologies at the Institute of Cardiovascular Medicine GmbH was founded in 2012 by Univ. Prof. Dr. Falko Skrabal. The aim of the company is twofold: the optimal care for patients with cardiovascular or metabolic diseases, and the development of new, non-invasive diagnostic methods.

Applying these methods we can not only optimize the care for our patients, but we can also provide these methods to other hospitals and scientifically interested physicians.

With the support of SFG and FFG the "CombynTM ECG" was developed as the initial project. The clinical validation of this "ECG of the Future" has already been published in 2014 and 2017 (article, article).